UNSPSC 51433407: Moexipril hydrochloride

This classification denotes an ace inhibitor with the molecular formula C27H34N2O7.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q1UMG3UH45, chemically known as 3-isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-, monohydrochloride, (3s-(2(r*(r*)),3r*))- but more generally known as moexipril hydrochloride, which bears US NIH Compound Identifier 54889.

UNSPSC 51433407 Moexipril hydrochloride is a Commodity code for a specific cardiovascular medication, but state and local procurement activity under this code shows limited direct match to the single-drug commodity designation. The recent opportunity data reflects state and local government buying of advanced life support medications more broadly — including multiple drug types supplied as bundled procurements for emergency medical services rather than moexipril specifically. The City of Tampa's April 2026 solicitation for Advanced Life Support Medications illustrates this pattern: the IFB called for four distinct medication line items (labetalol, epinephrine, adenosine, and diltiazem) in specified unit quantities for use by Tampa Fire Rescue. Issuing bodies under this code tier include municipal fire and emergency services departments and their procurement offices. The Commodity code itself sits within the broader pharmaceutical supply chain, but recent activity suggests state and local buyers typically aggregate multiple medications into single procurements rather than acquiring moexipril in isolation.

Geographic activity centers on Florida, with the Tampa procurement representing the most recent documented state and local opportunity. The City of Tampa issued IFB 26P00188 due April 8, 2026 (posted April 24, 2026), with an estimated contract value of $40,000 and a one-year term plus two optional one-year renewals and up to three additional 30-day unilateral extensions. The solicitation included a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount capped at $10,000, required WCAG 2.2 Level AA accessibility documentation, and OSHA-compliant Safety Data Sheets for all supplied medications. Delivery requirements mandated a nine-month minimum expiration date and ten-calendar-day delivery from order receipt, with vendor responsibility for pickup and replacement of expired stock. Award went to the lowest responsive, responsible bidder within 120 days of bid opening.